학술논문
Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARL
Document Type
Article
Author
Martin, M.; Zielinski, C.; Ruiz-Borrego, M.; Carrasco, E.; Turner, N.; Ciruelos, E.M.; Muñoz, M.; Bermejo, B.; Margeli, M.; Anton, A.; Kahan, Z.; Csöszi, T.; Casas, M.I.; Murillo, L.; Morales, S.; Alba, E.; Gal-Yam, E.; Guerrero-Zotano, A.; Calvo, L.; de la Haba-Rodriguez, J.; Ramos, M.; Alvarez, I.; Garcia-Palomo, A.; Huang Bartlett, C.; Koehler, M.; Caballero, R.; Corsaro, M.; Huang, X.; Garcia-Sáenz, J.A.; Chacón, J.I.; Swift, C.; Thallinger, C.; Gil-Gil, M.
Source
In Annals of Oncology April 2021 32(4):488-499
Subject
Language
ISSN
0923-7534